Prepare Now with the Help of Experts

Our 2021 Pharma Outlook report has been published in collaboration with some of Pharma’s biggest names to provide key insights that will help you navigate the next 12 months and grow your business.

Event Related News

Coronavirus Update

CPhI, ICSE, P-MEC, bioLIVE & Hi Korea 2020 Postponed until 2021

Thank you for your continued support of CPhI, ICSE, P-MEC, bioLIVE & Hi Korea.  After careful consultation with key industry members, we have taken the difficult but necessary decision to postpone the show from 26-28 August 2020 at COEX to 2021.

The Booming Indian Pharma Market

Drive for Generics Sees Korea Increasingly Attractive to International Pharma

Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and a robust generics market.

Business Etiquette in South Korea

Whether you’re a visitor or an exhibitor, it’s likely – if you’re using your International Meetings account – that you’ll have plenty of meetings with potential partners to attend onsite. To help you make the most out of each of your meetings and smoothly navigate your way through any cultural differences, we have compiled some business etiquette tips

Healthcare & Life Science Review by Pharmaboardroom

This report covers the areas within the life sciences where Korea is gathering an increasingly strong international reputation, highlighting the country’s progress in R&D and clinical trials, its thriving biotech ecosystem, and its growing footprint in the exciting field of regenerative medicine..

Industry Forecast for The Korean Pharma Market

Industry forecast for the Korean pharmaceutical market.  Source: BMI Research. Strong demand: Korea’s pharmaceutical market is set to expand at a steady pace over the coming years. An amicable market: As indicated by universal healthcare coverage and high purchasing power. 2.8%: 10-year compound annual growth rate (CAGR). Medical launche:; A primary market alongside Australia, Canada, the US, Japan and Western Europe.

The Booming Indian Pharma Market

Korea Pharma Development over the last 30 Years

1989: Universal health coverage for South Korean population. 1991: Korea joins the World Health Organization Programme for International Drug Monitoring . 1996: Korea Food and Drug Safety and its six regional offices are established. 1998: The government agency is raised to the status of administration: Korea Food & Drug Administration. Learn more!

Key Factors Influencing the Korean Pharma Market

Key Statistics: 4th largest pharmaceutical market in the Asia Pacific, Ranked 1st in 2018 Bloomberg Innovation Index, Home to over 40 pharmaceutical multinationals, Global biotech and medical industry hub by 2020. Learn more!

The Booming Indian Pharma Market

Pharma Outlook: 12 Trends to Watch in 2019

What does 2019 have in store for Pharma? We asked industry Thought Leaders to name one disruptive trend or technology that will have a significant impact on the market in the year ahead. Will pricing pressure lead to a shift in budget management? Is this the year for biosimilar approvals? Will we see continued M&A activity in the sector?

Unlocking the potential of Chinese medicine

Traditional Chinese medicine (TCM) has been used within China for thousands of years. Comprising practices such as herbal pharmacology, acupuncture and massage, it is grounded in the belief that the body is a system of balance, with a vital energy (chi) circulating around it in channels. When there are imbalances in the body, disease ensues.

South Korean Pharma Rapidly Becoming Manufacturing Export Hub

This surge in international companies wanting to partner in Korea reflects a flourishing South Korean pharma economy, which, in recent years, has become the 3rd largest pharma region in Asia, with a forecasted growth from $18.6 billion in 2016 to $20.4 billion in 2020.

The Booming Indian Pharma Market

CPhI Annual Industry Report 2018

The CPhI Annual Report is a comprehensive and critically important publication that analyses key trends and innovations forecast by our panel of world class experts.

IQVIA™ Market Prognosis 2018-2022

IQVIA and CPhI are pleased to bring you our special Market Prognosis report sharing our view of the future of the South Korean pharma market. Both CPhI and IQVIA consider that such information is key for the growth and development of the pharma industry and believe that this report will provide valuable insight as you look to develop your business in South Korea.